Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 3
1982 1
1983 4
1984 1
1985 4
1986 7
1987 8
1988 3
1989 13
1990 3
1991 1
1992 3
1993 6
1994 7
1995 5
1996 3
1997 4
1998 5
1999 9
2000 4
2001 8
2002 6
2003 4
2004 7
2005 10
2006 7
2007 6
2008 6
2009 13
2010 10
2011 11
2012 12
2013 16
2014 10
2015 8
2016 5
2017 1
2018 5
2019 5
2020 5
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Results by year
Filters applied: . Clear all
Page 1
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. Ishimoto T, et al. Among authors: masuko t. Cancer Cell. 2011 Mar 8;19(3):387-400. doi: 10.1016/j.ccr.2011.01.038. Cancer Cell. 2011. PMID: 21397861 Free article.
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.
Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, Wada T, Masuko T, Mogushi K, Tanaka H, Osawa T, Kanki Y, Minami T, Aburatani H, Ohmura M, Kubo A, Suematsu M, Takahashi K, Saya H, Nagano O. Yae T, et al. Among authors: masuko t. Nat Commun. 2012 Jun 6;3:883. doi: 10.1038/ncomms1892. Nat Commun. 2012. PMID: 22673910 Free article.
Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
Isobe S, Kataoka M, Endo J, Moriyama H, Okazaki S, Tsuchihashi K, Katsumata Y, Yamamoto T, Shirakawa K, Yoshida N, Shimoda M, Chiba T, Masuko T, Hakamata Y, Kobayashi E, Saya H, Fukuda K, Sano M. Isobe S, et al. Among authors: masuko t. Am J Respir Cell Mol Biol. 2019 Sep;61(3):367-379. doi: 10.1165/rcmb.2018-0231OC. Am J Respir Cell Mol Biol. 2019. PMID: 30897333
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers.
Okita K, Okazaki S, Uejima S, Yamada E, Kaminaka H, Kondo M, Ueda S, Tokiwa R, Iwata N, Yamasaki A, Hayashi N, Ogura D, Hirotani K, Yoshioka T, Inoue M, Masuko K, Masuko T. Okita K, et al. Among authors: masuko t. Oncotarget. 2020 Jan 7;11(1):31-45. doi: 10.18632/oncotarget.27414. eCollection 2020 Jan 7. Oncotarget. 2020. PMID: 32002122 Free PMC article.
237 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page